Bryan Dechairo

Diagnostic developer | CEO at @Sherlock_Bio | PhD from @UCL | Integrative Biology @UC Berkeley

[Bryan Dechairo @BryanDechairo]

Our @Sherlock_Bio team is committed to breaking down diagnostic barriers to democratize and decentralize healthcare. Thank you to our partners at @illuminaventure for this exciting write-up of our work to put highly-accurate #diagnostics in the hands of people around the world.

[Sherlock Biosciences @Sherlock_Bio]

Thank you @illuminaventure for this profile on Sherlock Biosciences, detailing how we are harnessing CRISPR, synthetic biology, and AI to create decentralized molecular diagnostic tests for the home and low resource settings.

https://t.co/RyXbHUzUrG

[Bryan Dechairo @BryanDechairo]

I'm thrilled to announce that Maurice Exner has joined @Sherlock_bio as Chief Scientific Officer. His expertise in research strategy will ensure further innovations in our proprietary chemistries and drive rapid assay design and development for our platform.

[Sherlock Biosciences @Sherlock_Bio]

Today we welcome Maurice Exner as Chief Scientific Officer. Maurice will lead our scientific research strategy to advance Sherlock's novel #CRISPR and synthetic biology-based chemistries to bring our innovative diagnostic technologies to the point-of-need.
https://t.co/WVcynBYHIF

[Bryan Dechairo @BryanDechairo]

On this #WorldHealthDay, I reflect on @Sherlock_Bio's mission to democratize and decentralize testing with novel #CRISPR diagnostics, so that people around the world have equitable access to healthcare.

Together, we can help make #HealthForAll a reality.

[Sherlock Biosciences @Sherlock_Bio]

Sherlock Biosciences is committed to breaking down barriers to healthcare access by bringing novel CRISPR-based diagnostics to everyone, anywhere in the world.

On this #WorldHealthDay, and every day that follows, we join the @WHO on the journey to achieve #HealthForAll.

[Sherlock Biosciences @Sherlock_Bio]

Today our Senior Deep Learning Engineer, Natasha Seelam, joined @phenomenashlie of @amazon and @maritza_johnson of @uofsandiego for a panel hosted by @SingleStoreDB to discuss using #AI to achieve equity and remove barriers.

Watch here:
https://t.co/wf1Z9GBnKn
#EmbraceEquity

[Sherlock Biosciences @Sherlock_Bio]

Natasha Seelam, our Senior Deep Learning Engineer, will join a panel of leaders in the field of #AI to discuss how technology can be used to achieve equity and remove barriers to justice.

Register for the event hosted by @SingleStoreDB on Monday 3/27:
https://t.co/wf1Z9GBnKn

[Sherlock Biosciences @Sherlock_Bio]

Our VP of HR, Tiffany Summerville, will share three strategies for organizations to promote an intentional culture of diversity, equity, engagement and inclusion.

Watch tip number one in this series to learn how incentivizing managers can make #DEI more effective.

[Bryan Dechairo @BryanDechairo]

Today’s patent news is an important milestone for @Sherlock_Bio and public health, bringing us closer delivering powerful, over-the-counter diagnostics that will give consumers more control over their health. #biotech #syntheticbiology

[Sherlock Biosciences @Sherlock_Bio]

Today’s granted patent by @USPTO is an important step on our pathway to commercialization of #CRISPR-based #diagnostics. #biotech #syntheticbiology
https://t.co/Vy3pfhdMzf

[Bryan Dechairo @BryanDechairo]

Thank you @GENbio's @GrinsteinJ for speaking with me about @Sherlock_bio’s acquisition of @sensedx1. This deal is a win for global public health, advancing our mission to deliver accessible, affordable & accurate #diagnostics to global consumers. #biotech
https://t.co/oEwgeUhaYv

[Sherlock Biosciences @Sherlock_Bio]

Our Principal Machine Learning Scientist, Pradeep Ramesh, predicts that #AI will become more data efficient in the life sciences in 2023.

Read his predictions for the coming of age of #ArtificialIntelligence in Trendspotting for 2023 in @bioitworld:
https://t.co/iEsFmF4tUl

[Bryan Dechairo @BryanDechairo]

Congratulations to David Walt on receiving this award. David is recognized by the @theNAEng for the profound impact of his microwell array invention on diagnostics and therapeutics. His innovation is foundational to our mission @Sherlock_Bio.

[Sherlock Biosciences @Sherlock_Bio]

Sherlock celebrates our Co-founder, David Walt, recipient of the 2023 Fritz J. and Dolores H. Russ Prize for his achievements in bioengineering.

David's work has advanced genomics, transformed #diagnostics, and impacts millions of people.
https://t.co/psBFRmMmfj

[Bryan Dechairo @BryanDechairo]

This story by @zoya__qureshi explores the frustration with the accuracy/convenience compromise of rapid tests. We're working to eliminate this trade-off @Sherlock_bio with our molecular diagnostics, bringing affordable, accurate tests to the point of need.
https://t.co/EYe5o9GDfa

[Bryan Dechairo @BryanDechairo]

Rain or shine, I'll be in SF next week with the @Sherlock_Bio team. Looking forward to joining @statnews for STAT@JPM What's Next for #Biotech on Monday.
#JPM2023 #JPM23

See you there:
https://t.co/1EEuvFKuk4

[Bryan Dechairo @BryanDechairo]

We are deeply grateful for the support of the @gatesfoundation, as we seek to disrupt #diagnostics. This grant will enable us to advance critical milestones to bring powerful diagnostic products to the point of need.

[Sherlock Biosciences @Sherlock_Bio]

We're grateful for @gatesfoundation's support as we continue our journey to transform human health worldwide.

This funding enables Sherlock to advance our platform for power-free #diagnostics to expand access and improve global health.

https://t.co/n4Rz855R2X

[Bryan Dechairo @BryanDechairo]

I'm thrilled to announce @Sherlock_Bio & Tolo Biotech's expanded collaboration, which enables us to further advance the development & adoption of #CRISPR #diagnostic technologies globally, improving public health & helping people access answers to control their health decisions.

[Sherlock Biosciences @Sherlock_Bio]

Sherlock and Tolo Biotech's license agreement collaboration grants both partners co-exclusive rights to the most comprehensive portfolio of #diagnostic #CRISPR patents globally. #biotech

Read more:
https://t.co/ZRZqNbsqHl

[Bryan Dechairo @BryanDechairo]

Thank you @tweetMadeleine for speaking with me about @Sherlock_Bio's license to ambient temperature amplification technology developed by our Co-Founder Jim Collins' lab at @wyssinstitute. Read her story in @GenomeWeb to learn how this tech will enable decentralized #diagnostics

[Sherlock Biosciences @Sherlock_Bio]

Our CEO @BryanDechairo spoke with @GenomeWeb's @tweetMadeleine about our newly licensed ambient temperature amplification tech from @HarvardTechXfer @wyssinstitute and how it enables us to create #diagnostic tests for #InfectiousDiseases #Biotech
https://t.co/iN8jwpG27T

[Bryan Dechairo @BryanDechairo]

Sherlock is a step closer to unlocking the potential of #CRISPR and breaking down diagnostic barriers globally by integrating this ambient temperature amplification method developed by Jim Collins' lab at @wyssinstitute and @MIT with our SHERLOCK™ platform.

[Sherlock Biosciences @Sherlock_Bio]

This license from @HarvardTechXfer for ambient temperature amplification developed by our Co-Founder Jim Collins's lab at @wyssinstitute and @MIT enables Sherlock to advance #CRISPR-based diagnostics for the point-of-need and low-resource settings.

https://t.co/SGD4L8y9nI

[Bryan Dechairo @BryanDechairo]

Exciting day for our 221b Foundation as we welcome @PardisSabeti to the board. Her counsel will be invaluable as we further our mission. #GlobalHealth

[Sherlock Biosciences @Sherlock_Bio]

On the two-year anniversary of The 221b Foundation, our Co-Founder @PardisSabeti joins the Board of Directors to support the foundation's mission to expand access to #CRISPR-based diagnostics globally.
#GlobalHealth
https://t.co/rUlgUXT1h9

[Bryan Dechairo @BryanDechairo]

Thank you @minu_pr for speaking with me for #CRISPR Cuts Podcast about my career journey and the @Sherlock_Bio team’s efforts developing novel next-generation #diagnostics for the point-of-need.

Listen here:
https://t.co/0zXu9UNNaM

[Sherlock Biosciences @Sherlock_Bio]

Our CEO @BryanDechairo will speak on a panel about the role of #CRISPR diagnostics in dental innovation & technology development for #oralhealth at @ForsythResearch's Dentech 2022 Conference on September 15 at 10am EST.

Register here:
https://t.co/gXFEg2UWz0

[Bryan Dechairo @BryanDechairo]

I just donated for Kevin Lind in the Pan-Mass Challenge. Click here to support your rider! #PMC2022 https://t.co/ij4ML0vf65 via @panmass